(E)-6-Methyl-4'-amino-2-styrylquinoline (3) is a small molecule with the proper features to potentially diagnose, deliver therapy and monitor response to therapy in protein misfolding diseases. These features include compound fluorescent emission in the NIR region and its ability to interact with both Aβ and prion fibrils, staining them with high selectivity. Styrylquinoline 3 also inhibits Aβ self-aggregation in vitro and prion replication in the submicromolar range in a cellular context. Furthermore, it is not toxic and is able to cross the blood brain barrier in vitro (PAMPA test).

A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases / Staderini, M; Aulić, S; Bartolini, M; Tran, Hna; GONZÁLEZ RUIZ, V; Pérez, Di; Cabezas, N; Martínez, A; Martín, Am; Andrisano, V; Legname, Giuseppe; Menéndez, Jc; Bolognesi, Ml. - In: ACS MEDICINAL CHEMISTRY LETTERS. - ISSN 1948-5875. - 4:2(2012), pp. 225-229. [10.1021/ml3003605]

A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases

Legname, Giuseppe;
2012-01-01

Abstract

(E)-6-Methyl-4'-amino-2-styrylquinoline (3) is a small molecule with the proper features to potentially diagnose, deliver therapy and monitor response to therapy in protein misfolding diseases. These features include compound fluorescent emission in the NIR region and its ability to interact with both Aβ and prion fibrils, staining them with high selectivity. Styrylquinoline 3 also inhibits Aβ self-aggregation in vitro and prion replication in the submicromolar range in a cellular context. Furthermore, it is not toxic and is able to cross the blood brain barrier in vitro (PAMPA test).
2012
4
2
225
229
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027132/
Staderini, M; Aulić, S; Bartolini, M; Tran, Hna; GONZÁLEZ RUIZ, V; Pérez, Di; Cabezas, N; Martínez, A; Martín, Am; Andrisano, V; Legname, Giuseppe; Me...espandi
File in questo prodotto:
File Dimensione Formato  
ml3003605.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 1.49 MB
Formato Adobe PDF
1.49 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11767/15980
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 48
social impact